1. Incidence of atrial fibrillation in different major cancer subtypes: a nationwide population-based 12 year follow up study;Jakobsen;BMC Cancer,2019
2. Cancer and atrial fibrillation: epidemiology, mechanisms, and anticoagulation treatment;Menichelli;Prog Cardiovasc Dis,2021
3. Efficacy and safety of rivaroxaban vs warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF;Chen;Eur Heart J Qual Care Clin Outcomes,2019
4. Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: analysis of the ENGAGE AF - TIMI 48 trial;Fanola;J Am Heart Assoc,2018
5. Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study;Pastori;Cancer,2021